Agilent Technologies Yönetim

Yönetim kriter kontrolleri 4/4

Agilent Technologies CEO'su Padraig McDonnell, May2024 tarihinde atandı, in görev süresi bir yıldan az. in toplam yıllık tazminatı $ 3.27M olup, şirket hissesi ve opsiyonları dahil olmak üzere 18.5% maaş ve 81.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.008% ine doğrudan sahiptir ve bu hisseler € 2.91M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5 yıl ve 7.9 yıldır.

Anahtar bilgiler

Padraig McDonnell

İcra Kurulu Başkanı

US$3.3m

Toplam tazminat

CEO maaş yüzdesi	18.5%
CEO görev süresi	less than a year
CEO sahipliği	0.008%
Yönetim ortalama görev süresi	5yrs
Yönetim Kurulu ortalama görev süresi	7.9yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Padraig McDonnell'un ücretlendirmesi Agilent Technologies'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jul 31 2024	n/a	n/a	US$1b
Apr 30 2024	n/a	n/a	US$1b
Jan 31 2024	n/a	n/a	US$1b
Oct 31 2023	US$3m	US$606k	US$1b
Jul 31 2023	n/a	n/a	US$1b
Apr 30 2023	n/a	n/a	US$1b
Jan 31 2023	n/a	n/a	US$1b
Oct 31 2022	n/a	n/a	US$1b
Jul 31 2022	n/a	n/a	US$1b
Apr 30 2022	n/a	n/a	US$1b
Jan 31 2022	n/a	n/a	US$1b
Oct 31 2021	US$3m	US$495k	US$1b

Tazminat ve Piyasa: Padraig 'nin toplam tazminatı ($USD 3.27M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 4.83M ).

Tazminat ve Kazançlar: Padraig 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Padraig McDonnell

less than a year

Görev süresi

US$3,272,898

Tazminat

Mr. Padraig McDonnell serves as its CEO, President & Director since May 01, 2024. He served as Senior Vice President at Agilent Technologies, Inc. since May 1, 2020 until February 2024 and served as Chief...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Padraig McDonnell	CEO, President & Director	less than a year	US$3.27m	0.0084% € 2.9m
Robert McMahon	Senior VP & CFO	6.2yrs	US$4.81m	0.032% € 11.2m
Henrik Ancher-Jensen	Senior VP and President of Order Fulfillment & Supply Chain	11.2yrs	US$3.33m	0.029% € 10.0m
Rodney Gonsalves	Principal Accounting Officer	9.5yrs	Veri yok	0.0074% € 2.6m
John Kohl	Senior Vice President & Chief Information Officer	8.8yrs	Veri yok	Veri yok
Bret DiMarco	Senior VP	less than a year	Veri yok	Veri yok
Dominique Grau	Senior Vice President of Human Resources & Global Communications	10.3yrs	US$2.21m	0.021% € 7.4m
Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe	19.8yrs	Veri yok	Veri yok
Jenipher Dalton	Senior VP	3.9yrs	Veri yok	Veri yok
Philip Binns	Senior VP of Agilent and President of Life Sciences & Applied Markets Group	1.2yrs	Veri yok	0.0015% € 509.8k
Jonah Kirkwood	Senior Vice President	less than a year	Veri yok	Veri yok
Angelica Riemann	Senior Vice President	less than a year	Veri yok	0.0061% € 2.1m

5.0yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: AG8 'un yönetim ekibi deneyimli ve deneyimlidir ( 5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Padraig McDonnell	CEO, President & Director	less than a year	US$3.27m	0.0084% € 2.9m
Heidi Fields	Independent Director	24.8yrs	US$331.85k	Veri yok
Otis Brawley	Independent Director	3yrs	US$331.85k	0% € 0
George Scangos	Independent Director	13.8yrs	US$351.85k	0.0063% € 2.2m
Dow Wilson	Independent Director	6.7yrs	US$356.85k	0% € 0
Boon Hwee Koh	Independent Non-Executive Chairman	21.5yrs	US$486.85k	0.021% € 7.3m
Daniel Podolsky	Independent Director	9.3yrs	US$341.85k	0% € 0
Mala Anand	Independent Director	5.7yrs	US$331.85k	0.0044% € 1.5m
Mikael Dolsten	Independent Director	3.2yrs	US$341.85k	0.0020% € 690.2k
Susan Rataj	Independent Director	9.2yrs	US$341.85k	0.0093% € 3.2m

7.9yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: AG8 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.9 yıldır).

Agilent Technologies Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary

Insider recently sold €1.9m worth of stock

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Recent updates

Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024

Third quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Third quarter 2024 earnings released: EPS: US$0.97 (vs US$0.38 in 3Q 2023)

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance

Now 21% undervalued after recent price drop

Agilent Technologies, Inc. Receives FDA Approval for Mage-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent Technologies, Inc. (NYSE:A) acquired Sigsense Technologies, Inc.

Agilent Technologies, Inc. Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit

Agilent Technologies, Inc. to Report Q3, 2024 Results on Aug 21, 2024

Agilent Technologies, Inc.(NYSE:A) dropped from Russell 1000 Growth-Defensive Index

Now 25% undervalued after recent price drop

Agilent Technologies, Inc Appoints Bret Dimarco as Senior Vice President and Chief Legal Officer and Secretary

Now 20% undervalued after recent price drop

Insider recently sold €1.9m worth of stock

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Now 23% undervalued after recent price drop

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

Second quarter 2024 earnings released: EPS: US$1.05 (vs US$1.02 in 2Q 2023)

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Now 21% undervalued

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024

Agilent Technologies, Inc. Announces New Proteoanalyzer System

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Makes Strategic Updates to Organizational Structure

Insider recently sold €1.9m worth of stock

Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader

Full year 2023 earnings released: EPS: US$4.22 (vs US$4.19 in FY 2022)

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Now 20% undervalued after recent price drop

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023

Now 22% undervalued after recent price drop

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A).

Now 20% undervalued

Agilent Technologies, Inc. Announces Management Changes

Agilent Technologies, Inc. Appoints Philip Binns as President of Life Sciences and Applied Markets Group

New minor risk - Earnings quality

Agilent Technologies, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.38 (vs US$1.10 in 3Q 2022)

Agilent Technologies, Inc. to Report Q3, 2023 Results on Aug 15, 2023

Agilent Technologies Inc. Announces the Launch of New Gen6 Software for All Agilent BioTek Detection Instruments

Upcoming dividend of US$0.23 per share at 0.8% yield

Agilent Technologies Inc. Introduces New Comprehensive GPC/SEC Solutions At HPLC 2023 Conference

Agilent Announces Biotek 406 Fx Washer Dispenser for Technology-Driven Workflow Efficiency

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Full Year Ended 2023

Second quarter 2023 earnings released: EPS: US$1.02 (vs US$0.92 in 2Q 2022)

Agilent Technologies, Inc. Announces Cash Dividend, Payable on July 26, 2023

Upcoming dividend of US$0.23 per share at 0.7% yield

First quarter 2023 earnings released: EPS: US$1.19 (vs US$0.94 in 1Q 2022)

Agilent Technologies Inc. Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

Agilent Technologies, Inc., Annual General Meeting, Mar 15, 2023

Agilent Technologies, Inc. to Report Q1, 2023 Results on Feb 28, 2023